McCain diagnosed with brain cancer after treatment for blood clot

McCain diagnosed with brain cancer after treatment for blood clot

Published
Sen. John McCain (R-Ariz.) was elected in 2016 to his sixth Senate term. (Photo by Danielle Wilde)

WASHINGTON – Sen. John McCain (R-Ariz.) has been diagnosed with brain cancer following treatment last week to remove a blood clot, according to a Wednesday evening statement released by the Mayo Clinic Hospital at the request of the senator and his family.

“On Friday, July 14, Sen. John McCain underwent a procedure to remove a blood clot from above his left eye at Mayo Clinic Hospital in Phoenix. Subsequent tissue pathology revealed that a primary brain tumor known as a glioblastoma was associated with the blood clot,” the statement said.

Gliobastoma is an agressive cancer that forms in the brain or spinal cord, according to the Mayo Clinic’s online medical reference. The disease can be difficult to treat.

The statement said McCain is consulting with both Mayo Clinic doctors and his family as to “further treatment options,” which “may include a combination of chemotherapy and radiation.”

McCain’s office on Wednesday evening released a follow-up statement that said the 80-year-old Vietnam veteran and former prisoner of war “is in good spirits as he continues to recover at home with his family in Arizona” and that: “Further consultations with Senator McCain’s Mayo Clinic care team will indicate when he will return to the United States Senate.”

The senator has been treated for skin cancer and had a dime-sized melanoma removed from his left temple in 2000 during his second bout with the disease. He has regular screenings for skin cancer.

McCain, whose potential long-term absence from Washington might further complicate passage of the GOP Senate health care bill, received an outflow of support from both Republicans and Democrats following news of the diagnosis.

  • Subscribe to Talk Media News

  • Subscribe to Quick Morning News

    Subscribe to the Talk Media News Daily Digest. Receive the top 10 stories each day in your inbox.

    Enter your email address below and click Subscribe.

  • NO COMMENTS

    Leave a Reply

    Your email address will not be published. Required fields are marked *